NatWest Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-827
Closed -$251K 432
2015
Q2
$251K Sell
827
-1,431
-63% -$427K ﹤0.01% 328
2015
Q1
$672K Buy
+2,258
New +$644K 0.01% 278
2013
Q4
Sell
-21,241
Closed -$3.06M 936
2013
Q3
$3.06M Sell
21,241
-391
-2% -$52.1K 0.09% 203
2013
Q2
$2.73M Buy
+21,632
New +$2.45M 0.04% 267

Other funds holding AGN

NatWest Group's AGN Position: Q3 2015 in Review

NatWest Group sold out of Allergan plc (AGN) in Q3 2015, closing a stake of 827 shares — an estimated $251K sold.

NatWest Group first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $3.06M in Q3 2013. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • NatWest Group reported no remaining Allergan plc position as of Q3 2015 after selling out during the quarter.
  • NatWest Group sold 827 Allergan plc shares in Q3 2015, an estimated $251K.
  • NatWest Group first reported a position in Allergan plc in Q2 2013 and held it in 4 quarters.
  • NatWest Group's Allergan plc position peaked at $3.06M in Q3 2013.
  • 1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on NatWest Group's 13F filing for Q3 2015, filed 13 Nov 2015.